AzTrials
AzTrials

Total Knee ArthroplastyNCT04748549

Intraoperative VR for Older Patients Undergoing TKA

A study testing Virtual Reality Immersive Relaxation and Immersive Audio Experience in people with Total Knee Arthroplasty, run by Beth Israel Deaconess Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this study is to investigate whether the use of virtual reality (VR) during total knee arthroplasty (TKA) can facilitate reductions in intraoperative sedative requirements while maintaining high levels of patient satisfaction as compared to both a music and sham VR + usual care control. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Total Knee Arthroplasty
What is being tested?
Virtual Reality Immersive Relaxation and Immersive Audio Experience
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
86 participants
Where
1 siteUnited States
Study dates
11 Apr 2022to 1 Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients age 60 or older undergoing primary total knee replacement surgery at BIDMC and receiving spinal/regional anesthesia
  • English or Spanish speaking patients

Who cannot join

  • Complex or revision surgeries
  • Patients scheduled for "same day" TKA
  • Open wounds or active infection of the face or eye area
  • History of seizures or other symptom linked to an epileptic condition
  • Patients who plan to wear hearing aids during the procedure
  • Patients with a pacemaker or other implanted medical device
Show all 11Show fewer
  • Droplet or airborne precautions (as determined by local infection control policy)
  • Non-English speaking or Non-Spanish speaking
  • Moderate to severe dementia
  • Drop-Out Criteria:
  • MoCA <10 (this test will be administered on Day of Enrollment)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215

Other trials in United States

About this study

Official title: Intraoperative Virtual Reality for Older Patients Undergoing Total Knee Arthroplasty

The objective of this study is to investigate whether the use of virtual reality (VR) during total knee arthroplasty (TKA) can facilitate reductions in intraoperative sedative requirements while maintaining high levels of patient satisfaction as compared to both a music and sham VR + usual care control.

Read the detailed description

The investigators will conduct a three-armed randomized controlled trial with the following aims:

Specific Aim 1: Evaluate whether the use of VR during TKA can facilitate a reduction in intraoperative propofol dose required for patient comfort as compared to music and sham VR + usual care controls.

Hypotheses: Patients in both the VR and music groups will demonstrate reductions in propofol dose compared to sham VR + usual care controls. A reduction in propofol dose between the VR and music group will be smaller in magnitude.

Specific Aim 2: Assess the effect of VR during TKA on patient reported outcomes including overall satisfaction, pain, and anxiety as compared to music and sham VR + usual care controls.

Hypotheses: Patients in the VR group will report significantly higher satisfaction and better control of pain and anxiety than those in the music group and usual care group.

Specific Aim 3: Explore the potential effects of VR during TKA on other key secondary outcomes of perioperative efficiency, postoperative cognition, and functional recovery.

Hypotheses: Patients in the VR group will have shorter post-anaesthesia care unit (PACU) length of stay as compared to sham VR + usual care controls. The effect of VR on postoperative delirium, postoperative cognitive decline, postoperative opioid use and functional recovery will be exploratory endpoints.

Being tested
Virtual Reality Immersive Relaxation, Immersive Audio Experience, Sham Virtual Reality Experience
Keywords
Virtual Reality

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality Immersive RelaxationOther

    The VR software developed allows patients to select from scenery such as mountains, the beach or from a selection of short videos, which are intended to promote relaxation.

  • Immersive Audio ExperienceOther

    A study team member will play from a library of music or other audible content (audiobook, podcast) that was preselected by the patient.

  • Sham Virtual Reality ExperienceOther

    Subjects will wear VR headsets and headphones but will not view any content or listen to any audible content.

Study groups in NCT04748549
Study groupRoleWhat they receive
Immersive VR groupExperimentalPatients in the Immersive VR group will don a VR headset connected to a software platform on a tablet, as well as noise cancelling headphones. Patients can choose their desired experience within the VR software from a selection of immersive environments and/or video content. Examples include sitting in a canoe on a river, on a peaceful meadow or in a forest. Patients also have the option to listen to guided meditation or select from a library of videos to watch on a web-based user interface. To reduce the influence of the anesthesia provider on the determination of sedative requirements, patients will administer their own sedation according to their needs for relaxation and comfort using a patient controlled system.
Receives: Other: Virtual Reality Immersive Relaxation
Music groupActive comparatorPatients randomized to the Music group will be equipped with VR headsets but won't view any content. They will also be equipped with noise cancelling headphones in the same fashion as the immersive VR group. A study team member will play from a library of music or other audible content (audiobook, podcast) that was preselected by the patient. Patients in the Sham VR group will also use patient controlled sedation.
Receives: Other: Immersive Audio Experience
Sham VR + Usual Care Control GroupSham comparatorSubjects in the control group will wear VR headsets and headphones but will not view any content or listen to any audible content. They will undergo Monitored Anesthesia Care (MAC) according to a prespecified protocol targeting light or moderate sedation with a propofol infusion.
Receives: Other: Sham Virtual Reality Experience

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intraoperative Propofol Dose

    Total propofol dose (mg/kg/min) administered intraoperatively

    Measured: Duration of the procedure, on average 1 to 3 hours

Secondary outcomes (9)
  1. Intraoperative and Postoperative Opioids

    Total intraoperative and postoperative opioid equivalent doses administered

    Measured: Duration of the procedure, on average 1 to 3 hours, and up until 72-hours postoperatively

  2. Intraoperative Anesthesia Maneuvers

    Assessment of intraoperative vital signs and anesthesia maneuvers potentially related to over-sedation (i.e. airway interventions, use of airway assist devices, conversion to general anesthesia)

    Measured: Duration of the procedure, on average 1 to 3 hours

  3. Length of PACU stay

    The length of the patients stay in the Post Anesthesia Care Unit.

    Measured: Duration of the patient's stay in the post anesthesia care unit, on average 1 to 5 hours

  4. Postoperative Pain

    Clinically documented pain scores will be recorded on a scale from 0 (best outcome) to 10 (worst outcome). Using this numeric rating scale, patients will be asked to describe both the maximum and average level of pain

    Measured: Measured on postoperative day zero and one, starting with PACU scores

  5. Satisfaction with Anesthesia

    Patients will rate their overall satisfaction with their perioperative anesthesia care using the Iowa Satisfaction with Anesthesia Scale. They will also be asked to rate their satisfaction with their communication with their anesthesia providers.

    Measured: Within an hour of admission to the postoperative anesthesia care unit

  6. Satisfaction with Recovery

    Patients will rate their overall satisfaction with their recovery from surgery using the QOR15. Additionally, patients will be asked how frequently they find themselves reacting to pain.

    Measured: Postoperative day one

  7. Postoperative Delirium

    A member of the research staff will meet with the patient and complete the 3-Minute Diagnostic Confusion Assessment Method (3D-CAM) to assess the incidence of postoperative delirium.

    Measured: Measured daily on each postoperative day, starting on postoperative day 1 until postoperative day 7.

  8. Delayed Cognitive Recovery and Postoperative Neurocognitive Disorder

    Cognitive function will be assessed using the telephonic version of the Montreal Cognitive Assessment (MoCA).

    Measured: Assessment will take place on day of enrollment and then at one week (+/- 48 hours) and one month postoperatively (+/- 7 days).

  9. Assessment of Knee Pain and Function

    As part of standard pre and post TKA assessment, patients will be administered the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement Patient-Reported Outcome Measures (KOOS-JR PROM) to assess the degree of limitation in activity and pain from their knee ailment.

    Measured: Assessments will take place within 7 days of the initial clinic visit and within 7 days of the initial postoperative clinic visit, typically one month after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2021
  2. Study start11 Apr 2022
  3. Primary completion1 Jun 2026
  4. Study completion1 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Research participants will be randomized to one of three groups (2:2:1 allocation): 1. Immersive VR group 2. Music group 3. Sham VR + usual care control The first 6 patients enrolled will be assigned to the VR group for the purposes of a pilot phase with the objective of identifying and refining any issues with the intervention. Data for these patients will not be included in the statistical analysis.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
86 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04748549
Sponsor's protocol ID
2020P001176
Status last verified
May 2026
First submitted
29 Jan 2021
Last updated
8 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Espinosa-Leon JP, Mathura R, Chen G, Joseph M, Sadhwani T, Beydoun N, Hernandez ER, Riley T, Kunze LJ, Goodspeed V, O'Gara BP. Intraoperative virtual reality for older patients undergoing total knee arthroplasty: study protocol for a randomized clinical trial. Trials. 2024 Dec 18;25(1):830. doi: 10.1186/s13063-024-08551-6.

    PubMed 39695824

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Immersive Relaxation and Immersive Audio Experience in people with Total Knee Arthroplasty, run by Beth Israel Deaconess Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intraoperative Propofol Dose (time frame: Duration of the procedure, on average 1 to 3 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04748549, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in